FDA clears Medtronic's blood-separation system
This article was originally published in Clinica
Medtronic has received US marketing clearance for what it claims is an improved method for separating a patient's own blood during surgery.
You may also be interested in...
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.